NEW YORK CITY (DA) — Jurickson Profar’s appeal of his 162-game suspension was unsuccessful, leaving the Atlanta Braves outfielder set to miss the entire 2026 season without pay.
The suspension stems from Profar testing positive for Exogenous Testosterone and its metabolites, a performance-enhancing substance, in violation of Major League Baseball’s Joint Drug Prevention and Treatment Program.
With the appeal now unsuccessful, Profar will serve the full 162-game suspension and be ineligible for postseason play if Atlanta qualifies.
Profar also will forfeit his $15 million salary for the season. The Braves, meanwhile, will avoid the $3 million in luxury tax payments that would have been tied to his contract this year.
After MLB’s original announcement, the Braves said they were “incredibly disappointed” to learn that Profar tested positive for a performance-enhancing substance and was found in violation of MLB’s Drug Prevention and Treatment Program.
Atlanta added that its players are consistently educated about the program and the consequences of violating it, and said the organization fully supports the policy.